Vascular Responses to Sympathetic Activation and Altered Shear Rate: The Impact of Hypertension and Sodium Intake

Not Applicable

Completed

• Conditions: Hypertension
• Interventions: Dietary Supplement: Salt Pills; Dietary Supplement: Placebo Pills

• Registration Number: NCT03558022
• Lead Sponsor: Virginia Commonwealth University

Brief Summary

The aim of this study is to determine if alterations in sodium intake alter peripheral vascular function and exercise tolerance in young individuals.

Detailed Description

Sodium intake is a major contributor to the development of hypertension in the developed world. Interestingly, it has been recently revealed that, in addition to the cardiovascular dysfunction associated with high sodium intake-induced hypertension, individuals who have unaltered blood pressure after chronic high sodium intake, termed salt resistant, report similar reductions in cardiovascular function when compared to salt sensitive individuals. While the extent to which this high sodium intake negatively alters cardiovascular structure as well as function is currently being explored, little is known about how high sodium intake impacts vascular function and blood flow regulation during exercise. Therefore, this study will determine if alterations in sodium intake alter peripheral vascular function and exercise tolerance in young individuals. The investigators hypothesize that increases in sodium intake will reduce exercise-induced arterial dilation in response to shear and result in exercise intolerance, via impaired functional sympatholysis, at moderate-to-high exercise workloads. Furthermore, the investigators hypothesize that these changes in blood flow regulation and exercise tolerance in young individuals will be reversed following antioxidant supplementation, implicating the role of oxidative stress in this dysfunction.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2018-05-15
• Study First Submitted: 2018-06-04
• Study First Submitted QC: 2018-06-04
• Study First Posted: 2018-06-15
• Primary Completion: 2021-11-05
• Study Completion: 2021-11-05
• Status Verified: 2023-01
• Last Update Submitted: 2023-01-12
• Last Update Posted: 2023-01-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

• normotensive blood pressure (Systolic <120 AND Diastolic <80
• free of cardiovascular disease and any evidence of thyroid, renal, metabolic, pulmonary or neurological disease
• non-obese (BMI <30 and/or Body fat < 25% for men, and < 30% for women)
• no tobacco use
• no medications that could affect vascular function or oxidative stress
• not sedentary

Read More

Exclusion Criteria

• individual with cardiovascular, pulmonary, or metabolic disease or taking medications that may alter cardiovascular, pulmonary, or metabolic function
• subjects will be asked to maintain a dietary record for one week subsequent to the pre-screening and if this reveals a diet that differs substantially from the "typical" average diet, the subject will not be eligible
• subjects will be excluded from the study if dietary records reveal significant caloric restriction and/or vitamin/mineral deficiencies
• pregnant women, prisoners, and children will not be eligible for this study

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Salt Pills	Salt Pills	One week on low salt diet plus salt pills
Placebo Pills	Placebo Pills	One week on low salt diet plus placebo pills

Primary Outcome Measures

Name	Time	Method
Arterial Dilation in Response to Exercise	After 7 day high salt supplementation vs After 7 day low salt supplementation	Percent change is arterial diameter when compared to baseline

Trial Locations

Locations (1)

Virginia Commonwealth University; 🇺🇸 Richmond, Virginia, United States